News Home

Is Arcturus Therapeutics Holdings Inc (ARCT) Stock a Good Value Tuesday?

Tuesday, May 24, 2022 11:49 AM | InvestorsObserver Analysts
Is Arcturus Therapeutics Holdings Inc (ARCT) Stock a Good Value Tuesday?

Arcturus Therapeutics Holdings Inc (ARCT) is around the top of the Healthcare sector according to InvestorsObserver. ARCT received an overall rating of 62, which means that it scores higher than 62% of stocks. Additionally, Arcturus Therapeutics Holdings Inc scored a 89 in the Healthcare sector, ranking it higher than 89% of stocks in that sector.

Overall Score - 62
ARCT has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ARCT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arcturus Therapeutics Holdings Inc Stock Today?

Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $17.52 as of 11:43 AM on Tuesday, May 24, a drop of -$0.56, or -3.07% from the previous closing price of $18.07. The stock has traded between $16.38 and $17.57 so far today. Volume today is light. So far 133,870 shares have traded compared to average volume of 771,072 shares. Click Here to get the full Stock Report for Arcturus Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App